Compare

Retatrutide vs SLU-PP-332

Side-by-side observational reports from PeptIQ users. This compares self-reported patterns — not clinical head-to-head trials.

Observational reporting only — not medical advice. Does not recommend doses, protocols, or treatments.
XRedditFacebook

Retatrutide

125 community reports

Positive 99% · Neutral 1% · Negative 0%

Most reported benefits

Appetite
222

Most reported side effects

Nausea
3

Dose distribution

Median: 2000+ mcg · Most common: 2000+ mcg

0–25
5
25–50
0
50–100
0
100–200
3
200–400
6
400–600
10
600–1000
5
1000–2000
80
2000+
113

How repeat users are trending

Among repeat reporters, 100% said they felt similar to their last entry, 0% more positive, and 0% more negative.

Overall, repeat reporters leaned similar or mixed compared to their previous entry.

Median gap between entries: 51 days · Based on 45 repeat reporters

SLU-PP-332

27 community reports

Positive 3% · Neutral 97% · Negative 0%

Most reported benefits

Energy
141
Appetite
141

Most reported side effects

Nausea
137

Dose distribution

Median: 2000+ mcg · Most common: 2000+ mcg

0–25
0
25–50
0
50–100
0
100–200
0
200–400
26
400–600
2
600–1000
1
1000–2000
5
2000+
107

How repeat users are trending

Among repeat reporters, 84% said they felt similar to their last entry, 16% more positive, and 0% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 94 days · Based on 25 repeat reporters